GoodRx Holdings, Inc. (GDRX)
2.525
+0.02
(+1.00%)
USD |
NASDAQ |
May 19, 16:00
2.52
0.00 (0.00%)
After-Hours: 20:00
GoodRx Holdings Research and Development Expense (Quarterly) : 30.18M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| American Well Corp. | 12.38M |
| DarioHealth Corp. | 2.385M |
| Retrieve Medical Holdings, Inc. | -- |
| Claritev Corp. | -- |
| Certara, Inc. | 12.29M |